Felix E. de Jongh
Impact in
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Hepatology top 5%
- Hepatitis C virus research
Papers in
- Oncology 19
- Cancer Treatment and Pharmacology 9
- Cancer Cells and Metastasis 3
- HER2/EGFR in Cancer Research 3
- Colorectal Cancer Treatments and Studies 3
-
- Chemotherapy-induced organ toxicity mitigation 5
- Co-authors
- Wim C.J. Hop (1 shared paper)M. van Blankenstein (1 shared paper)Harry L.A. Janssen (1 shared paper)Solko W. Schalm (1 shared paper)Robert A. de Man (1 shared paper)Jaap Verweij (7 shared papers)E. Maartense (5 shared papers)Tanja Čufer (3 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)European Journal of Cancer (4 papers)Annals of Oncology (3 papers)The Breast (2 papers)Journal of Molecular Diagnostics (1 paper)
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
Felix E. de Jongh
36 papers receiving 2.1k citations
Felix E. de Jongh's Hit Papers
Peers
Comparison fields: 5 of 91
- Oncology 1.0k
- Hepatology 242
- Geriatrics and Gerontology 81
- Cancer Research 301
- Pathology and Forensic Medicine 232
Countries citing papers authored by Felix E. de Jongh
This map shows the geographic impact of Felix E. de Jongh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix E. de Jongh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix E. de Jongh more than expected).
Fields of papers citing papers by Felix E. de Jongh
This network shows the impact of papers produced by Felix E. de Jongh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix E. de Jongh. The network helps show where Felix E. de Jongh may publish in the future.
Co-authors
The 25 scholars most cited alongside Felix E. de Jongh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study Hit paper breakdown → | 2009 | 505 |
| 2 | 1992 | 329 | |
| 3 | 2003 | 216 | |
| 4 | 2011 | 141 | |
| 5 | 2013 | 109 | |
| 6 | 2001 | 96 | |
| 7 | 2010 | 61 | |
| 8 | 2017 | 56 | |
| 9 | 2008 | 53 | |
| 10 | 2017 | 50 | |
| 11 | 2014 | 45 | |
| 12 | 2014 | 45 | |
| 13 | 2003 | 43 | |
| 14 | 2011 | 42 | |
| 15 | 2016 | 41 | |
| 16 | 2004 | 40 | |
| 17 | 2013 | 39 | |
| 18 | 2002 | 33 | |
| 19 | 2012 | 30 | |
| 20 | 2019 | 24 |
About Felix E. de Jongh
Felix E. de Jongh is a scholar working on Oncology, Pathology and Forensic Medicine, Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 36 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Chemotherapy-induced organ toxicity mitigation (5 papers), Cancer Genomics and Diagnostics (3 papers), Advanced Breast Cancer Therapies (3 papers), Breast Cancer Treatment Studies (3 papers), Cancer Cells and Metastasis (3 papers), HER2/EGFR in Cancer Research (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Oncology (1.0k citations), Hepatology (242 citations), Geriatrics and Gerontology (81 citations), Cancer Research (301 citations) and Pathology and Forensic Medicine (232 citations). Felix E. de Jongh has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Wim C.J. Hop, M. van Blankenstein, Harry L.A. Janssen, Solko W. Schalm, Robert A. de Man, Jaap Verweij, E. Maartense, Tanja Čufer, Sibylle Loibl and Gϋnter von Minckwitz. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, The Breast and Journal of Molecular Diagnostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.